Law360, New York (June 26, 2012, 1:53 PM EDT) -- Keith Pagnani is a partner in Sullivan & Cromwell LLP's New York office. He is co-head of the firm's health care and life sciences group and is a member of the firm's managing partners billing policy and diversity committees. He advises domestic and international clients in M&A transactions across various sectors, including pharmaceuticals, biotech and life sciences, medical devices, medical information systems and technologies, health providers, insurance and managed care. Recent representations include Alcon-Novartis ($50 billion), Valeant-Cephalon bid ($5.7 billion), ZOLL-Asahi Kasei ($2.21 billion), Medica HealthCare-United Healthcare, United Healthcare-XLHealth, IMS Health-TPG Capital/Canada Pension Plan ($5.2 billion) and Endo-Qualitest ($1.2 billion)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
